Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -1394.09% is 1189% below its 5-year average of -108.17%, near the low end of its 5-year range (-1394.09%–-31.32%).
As of the fiscal period ended Tuesday, June 30, 2026. 133.65% below its 12-month average of -596.65%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -1394.09%.
RETURN ON INVESTED CAPITAL (ROIC)
-1394.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-596.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-191.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-108.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-133.65%
CURRENT VS 3Y AVG
-629.06%
CURRENT VS 5Y AVG
-1188.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-3811.03%
vs the sector median at left
Jasper Therapeutics, Inc.
Market Cap
$9.10M
Return on Invested Capital (ROIC)
-1394.09%
TTM Avg
-596.65%
3Y Avg
-191.22%
5Y Avg
-108.17%
Market Cap
$9.05M
Return on Invested Capital (ROIC)
-325.63%
TTM Avg
-111.28%
3Y Avg
-111.28%
5Y Avg
-230.14%
Market Cap
$8.82M
Return on Invested Capital (ROIC)
-11.06%
TTM Avg
-74.47%
3Y Avg
-55.02%
5Y Avg
-81.57%
Market Cap
$9.50M
Return on Invested Capital (ROIC)
-80.51%
TTM Avg
-60.18%
3Y Avg
-50.63%
5Y Avg
-247.68%
Market Cap
$9.71M
Return on Invested Capital (ROIC)
-59.35%
TTM Avg
-68.11%
3Y Avg
-104.39%
5Y Avg
-133.77%
Market Cap
$9.75M
Return on Invested Capital (ROIC)
-215.61%
TTM Avg
-191.09%
3Y Avg
-141.72%
5Y Avg
-179.96%
Market Cap
$9.83M
Return on Invested Capital (ROIC)
-183.45%
TTM Avg
-213.20%
3Y Avg
-179.79%
5Y Avg
-169.02%
Market Cap
$9.86M
Return on Invested Capital (ROIC)
-55.13%
TTM Avg
-99.85%
3Y Avg
-167.97%
5Y Avg
-308.25%
Market Cap
$8.33M
Return on Invested Capital (ROIC)
-21.90%
TTM Avg
-47.33%
3Y Avg
-176.82%
5Y Avg
-106.87%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | $9.10M | -1394.09% | -596.65% | -191.22% | -108.17% |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.05M | -325.63% | -111.28% | -111.28% | -230.14% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $8.82M | -11.06% | -74.47% | -55.02% | -81.57% |
| Ainos, Inc. (AIMD)vs › | $9.50M | -80.51% | -60.18% | -50.63% | -247.68% |
| Satellos Bioscience Inc. (MSLE)vs › | $9.71M | -59.35% | -68.11% | -104.39% | -133.77% |
| MetaVia Inc. (MTVA)vs › | $9.75M | -215.61% | -191.09% | -141.72% | -179.96% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.83M | -183.45% | -213.20% | -179.79% | -169.02% |
| Valion Bio, Inc. (VBIO)vs › | $9.86M | -55.13% | -99.85% | -167.97% | -308.25% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.33M | -21.90% | -47.33% | -176.82% | -106.87% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | -269.16% | -387.93% | -400.47% | -400.47% |
ROIC
-1394.1%
ROE
-2248.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -1394.09% |
| 2026-03-31 | -599.22% |
| 2025-12-31 | -371.51% |
| 2025-09-30 | -256.20% |
| 2025-06-30 | -362.21% |
| 2025-03-31 | -183.30% |
| 2024-12-31 | -117.90% |
| 2024-09-30 | -78.98% |
| 2024-06-30 | -65.62% |
| 2024-03-31 | -59.79% |
| 2023-12-31 | -83.45% |
| 2023-09-30 | -65.87% |
| 2023-06-30 | -50.55% |
| 2023-03-31 | -40.01% |
| 2022-12-31 | -123.97% |
| 2022-09-30 | -95.83% |
| 2022-06-30 | -73.58% |
| 2022-03-31 | -58.14% |
| 2021-12-31 | -43.01% |
| 2021-09-30 | -31.32% |
| 2021-06-30 | -157.27% |
| 2021-03-31 | -96.04% |
| 2020-12-31 | -106.92% |
